SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $322,000 | -82.3% | 3,300 | -83.2% | 0.00% | -75.0% |
Q4 2014 | $1,819,000 | +78.7% | 19,600 | +32.4% | 0.00% | +33.3% |
Q3 2014 | $1,018,000 | +31.2% | 14,800 | +100.0% | 0.00% | +50.0% |
Q2 2014 | $776,000 | +66.9% | 7,400 | +32.1% | 0.00% | +100.0% |
Q1 2014 | $465,000 | -85.8% | 5,600 | -89.2% | 0.00% | -91.7% |
Q3 2013 | $3,279,000 | +609.7% | 51,800 | +370.9% | 0.01% | +500.0% |
Q2 2013 | $462,000 | +95.8% | 11,000 | +115.7% | 0.00% | +100.0% |
Q4 2012 | $236,000 | – | 5,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
Tradeworx Inc. | 2,936 | $308,000 | 0.25% |